SCHEMBL20256162

SCHEMBL20256162

COc1ccc(CN(Sc2cc(Cl)c(NCc3cccc4ccccc34)cc2F)c2nccs2)c(OC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 4/20 0.41
SCN5A Q14524 4/20 0.41
SCN8A Q9UQD0 4/20 0.41
CYP1A2 P05177 13/20 0.38
CYP3A4 P08684 13/20 0.38
CYP2D6 P10635 12/20 0.38
TSHR P16473 11/20 0.38
CYP2C19 P33261 11/20 0.38
LMNA P02545 4/20 0.38
CLK4 Q9HAZ1 3/20 0.38
ALDH1A1 P00352 2/20 0.38
GLA P06280 1/20 0.38
NPBWR1 P48145 2/20 0.37
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
MAPK1 P28482 1/20 0.36
USP2 O75604 3/20 0.36
CYP2C9 P11712 4/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HSD17B10 Q99714 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20256613 0.93 SCN1A (0.50) SCN1ASCN5ASCN8ACYP1A2CYP3A4
SCHEMBL20256174 0.91 CYP1A2 (0.37) SCN1ASCN5ASCN8ACYP1A2CYP3A4
SCHEMBL20256159 0.89 KMT2A (0.39) SCN1ASCN5ASCN8ACYP1A2CYP3A4
SCHEMBL20256130 0.89 CYP1A2 (0.37) SCN1ASCN5ASCN8ACYP1A2CYP3A4
SCHEMBL20256499 0.89 SCN1A (0.48) SCN1ASCN5ASCN8ACYP1A2CYP3A4
SCHEMBL20256699 0.88 KDM4E (0.38) SCN1ASCN5ASCN8ACYP1A2CYP3A4
SCHEMBL20256424 0.88 SCN1A (0.36) SCN1ASCN5ASCN8ACYP1A2CYP3A4
SCHEMBL20256471 0.87 ALDH1A1 (0.37) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL20256286 0.87 MAPT (0.37) SCN1ASCN5ASCN8ACYP1A2CYP3A4
SCHEMBL20256834 0.86 CYP1A2 (0.37) SCN1ASCN5ASCN8ACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018106284-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2018-06-14 WO disclosed